Literature DB >> 24107679

Novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease.

Kyongtae T Bae1, Cheng Tao, Jinhong Wang, Diana Kaya, Zhiyuan Wu, Junu T Bae, Arlene B Chapman, Vicente E Torres, Jared J Grantham, Michal Mrug, William M Bennett, Michael F Flessner, Doug P Landsittel.   

Abstract

OBJECTIVE: To evaluate whether kidney and cyst volumes can be accurately estimated based on limited area measurements from magnetic resonance (MR) images of patients with autosomal dominant polycystic kidney disease (ADPKD).
MATERIALS AND METHODS: MR coronal images of 178 ADPKD participants from the Consortium for Radiologic Imaging Studies of ADPKD (CRISP) were analyzed. For each MR image slice, we measured kidney and renal cyst areas using stereology and region-based thresholding methods, respectively. The kidney and cyst 'observed' volumes were calculated by summing up the area measurements of all the slices covering the kidney. To estimate the volume, we selected a coronal mid-slice in each kidney and multiplied its area by the total number of slices ('PANK2' for kidney and 'PANC2' for cyst). We then compared the kidney and cyst volumes predicted from PANK2 and PANC2, respectively, to the corresponding observed volumes, using a linear regression analysis.
RESULTS: The kidney volume predicted from PANK2 correlated extremely well with the observed kidney volume (R(2) = 0.994 for the right kidney and 0.991 for the left kidney). The linear regression coefficient multiplier to PANK2 that best fit the kidney volume was 0.637 (95% CI: 0.629-0.644) for the right kidney and 0.624 (95% CI: 0.616-0.633) for the left kidney. The correlation between the cyst volume predicted from PANC2 and the observed cyst volume was also very high (R(2) = 0.984 for the right kidney and 0.967 for the left kidney). The least squares linear regression coefficient for PANC2 was 0.637 (95% CI: 0.624-0.649) for the right kidney and 0.608 (95% CI: 0.591-0.625) for the left kidney.
CONCLUSION: Kidney and cyst volumes can be closely approximated by multiplying the product of the mid-slice area measurement and the total number of slices in the coronal MR images of ADPKD kidneys by 0.61-0.64. This information will help save processing time needed to estimate total kidney and cyst volumes of ADPKD kidneys.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 24107679      PMCID: PMC3863613          DOI: 10.1159/000355375

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  9 in total

1.  Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.

Authors:  Arlene B Chapman; James E Bost; Vicente E Torres; Lisa Guay-Woodford; Kyongtae Ty Bae; Douglas Landsittel; Jie Li; Bernard F King; Diego Martin; Louis H Wetzel; Mark E Lockhart; Peter C Harris; Marva Moxey-Mims; Mike Flessner; William M Bennett; Jared J Grantham
Journal:  Clin J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 8.237

Review 2.  Imaging for the prognosis of autosomal dominant polycystic kidney disease.

Authors:  Kyongtae T Bae; Jared J Grantham
Journal:  Nat Rev Nephrol       Date:  2010-02       Impact factor: 28.314

3.  Volume progression in polycystic kidney disease.

Authors:  Jared J Grantham; Vicente E Torres; Arlene B Chapman; Lisa M Guay-Woodford; Kyongtae T Bae; Bernard F King; Louis H Wetzel; Deborah A Baumgarten; Phillip J Kenney; Peter C Harris; Saulo Klahr; William M Bennett; Gladys N Hirschman; Catherine M Meyers; Xiaoling Zhang; Fang Zhu; John P Miller
Journal:  N Engl J Med       Date:  2006-05-18       Impact factor: 91.245

4.  Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease.

Authors:  K T Bae; P K Commean; J Lee
Journal:  J Comput Assist Tomogr       Date:  2000 Jul-Aug       Impact factor: 1.826

5.  Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).

Authors:  W Charles O'Neill; Michelle L Robbin; Kyongtae T Bae; Jared J Grantham; Arlene B Chapman; Lisa M Guay-Woodford; Vicente E Torres; Bernard F King; Louis H Wetzel; Paul A Thompson; J Philip Miller
Journal:  Am J Kidney Dis       Date:  2005-12       Impact factor: 8.860

6.  Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.

Authors:  Arlene B Chapman; Lisa M Guay-Woodford; Jared J Grantham; Vicente E Torres; Kyongtae T Bae; Deborah A Baumgarten; Philip J Kenney; Bernard F King; James F Glockner; Louis H Wetzel; Marijn E Brummer; W Charles O'Neill; Michelle L Robbin; William M Bennett; Saulo Klahr; Gladys H Hirschman; Paul L Kimmel; Paul A Thompson; J Philip Miller
Journal:  Kidney Int       Date:  2003-09       Impact factor: 10.612

7.  Tolvaptan in patients with autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Arlene B Chapman; Olivier Devuyst; Ron T Gansevoort; Jared J Grantham; Eiji Higashihara; Ronald D Perrone; Holly B Krasa; John Ouyang; Frank S Czerwiec
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

8.  Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.

Authors:  Kyongtae T Bae; Fang Zhu; Arlene B Chapman; Vicente E Torres; Jared J Grantham; Lisa M Guay-Woodford; Deborah A Baumgarten; Bernard F King; Louis H Wetzel; Philip J Kenney; Marijn E Brummer; William M Bennett; Saulo Klahr; Catherine M Meyers; Xiaoling Zhang; Paul A Thompson; J Philip Miller
Journal:  Clin J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 8.237

9.  MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement.

Authors:  Kyongtae T Bae; Cheng Tao; Fang Zhu; James E Bost; Arlene B Chapman; Jared J Grantham; Vicente E Torres; Lisa M Guay-Woodford; Catherine M Meyers; William M Bennett
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

  9 in total
  15 in total

1.  The association of endothelin-1 levels with renal survival in polycystic kidney disease patients.

Authors:  Ismail Kocyigit; Eray Eroglu; Ahmet Safa Kaynar; Derya Kocer; Seval Kargi; Gokmen Zararsiz; Ruslan Bayramov; Hakan Imamoglu; Murat Hayri Sipahioglu; Bulent Tokgoz; Munis Dundar; Oktay Oymak
Journal:  J Nephrol       Date:  2018-07-18       Impact factor: 3.902

2.  Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Kyongtae T Bae; Wen Zhou; Chengli Shen; Douglas P Landsittel; Zhiyuan Wu; Cheng Tao; Arlene B Chapman; Vicente E Torres; Alan S L Yu; Michal Mrug; William M Bennett; Peter C Harris
Journal:  Clin J Am Soc Nephrol       Date:  2019-05-14       Impact factor: 8.237

3.  Standardizing total kidney volume measurements for clinical trials of autosomal dominant polycystic kidney disease.

Authors:  Marie E Edwards; Jaime D Blais; Frank S Czerwiec; Bradley J Erickson; Vicente E Torres; Timothy L Kline
Journal:  Clin Kidney J       Date:  2018-08-29

4.  Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression.

Authors:  Timothy L Kline; Panagiotis Korfiatis; Marie E Edwards; Joshua D Warner; Maria V Irazabal; Bernard F King; Vicente E Torres; Bradley J Erickson
Journal:  Nephrol Dial Transplant       Date:  2015-08-31       Impact factor: 5.992

5.  Novel semi-automated kidney volume measurements in autosomal dominant polycystic kidney disease.

Authors:  Satoru Muto; Haruna Kawano; Shuji Isotani; Hisamitsu Ide; Shigeo Horie
Journal:  Clin Exp Nephrol       Date:  2017-11-03       Impact factor: 2.801

6.  A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.

Authors:  Harpreet Bhutani; Vikram Smith; Frederic Rahbari-Oskoui; Ankush Mittal; Jared J Grantham; Vicente E Torres; Michal Mrug; Kyongtae T Bae; Zhiyuan Wu; Yinghui Ge; Doug Landslittel; Patrice Gibbs; W Charles O'Neill; Arlene B Chapman
Journal:  Kidney Int       Date:  2015-04-01       Impact factor: 10.612

7.  Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients.

Authors:  Atieh Makhlough; Soroosh Shekarchian; Reza Moghadasali; Behzad Einollahi; Seyedeh Esmat Hosseini; Neda Jaroughi; Tina Bolurieh; Hossein Baharvand; Nasser Aghdami
Journal:  Stem Cell Res Ther       Date:  2017-05-23       Impact factor: 6.832

8.  Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease.

Authors:  Kanishka Sharma; Anna Caroli; Le Van Quach; Katja Petzold; Michela Bozzetto; Andreas L Serra; Giuseppe Remuzzi; Andrea Remuzzi
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

9.  Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease: A Canadian Expert Consensus.

Authors:  Steven Soroka; Ahsan Alam; Micheli Bevilacqua; Louis-Philippe Girard; Paul Komenda; Rolf Loertscher; Philip McFarlane; Sanjaya Pandeya; Paul Tam; Daniel G Bichet
Journal:  Can J Kidney Health Dis       Date:  2017-03-01

10.  Automatic Segmentation of Kidneys using Deep Learning for Total Kidney Volume Quantification in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Kanishka Sharma; Christian Rupprecht; Anna Caroli; Maria Carolina Aparicio; Andrea Remuzzi; Maximilian Baust; Nassir Navab
Journal:  Sci Rep       Date:  2017-05-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.